ClearBridge Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

ClearBridge Investments’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-105,901	Closed	-$12.3M	–	770
2023 Q3	$12.3M	Sell	105,901 -122,759	-54%	-$13.2M	0.01%	491
2023 Q2	$23.5M	Sell	228,660 -436,054	-66%	-$46M	0.02%	421
2023 Q1	$72.5M	Sell	664,714 -484,516	-42%	-$53.6M	0.07%	257
2022 Q4	$131M	Sell	1,149,230 -431,918	-27%	-$35.9M	0.13%	161
2022 Q3	$97.9M	Sell	1,581,148 -168,877	-10%	-$11.8M	0.1%	199
2022 Q2	$140M	Sell	1,750,025 -48,455	-3%	-$4.59M	0.13%	151
2022 Q1	$189M	Buy	1,798,480 +191,259	+12%	+$18.6M	0.14%	151
2021 Q4	$173M	Buy	1,607,221 +163,964	+11%	+$17.9M	0.12%	168
2021 Q3	$158M	Buy	1,443,257 +39,237	+3%	+$4.07M	0.11%	175
2021 Q2	$131M	Buy	1,404,020 +348,296	+33%	+$32.1M	0.09%	199
2021 Q1	$97.2M	Buy	1,055,724 +446,215	+73%	+$37.7M	0.07%	225
2020 Q4	$44.6M	Buy	+609,509	New	+$45.3M	0.03%	346
2017 Q1	–	Sell	-63,520	Closed	-$1.03M	–	1181
2016 Q4	$1.03M	Hold	63,520	–	–	﹤0.01%	679
2016 Q3	$1.15M	Hold	63,520	–	–	﹤0.01%	666
2016 Q2	$1.05M	Hold	63,520	–	–	﹤0.01%	680
2016 Q1	$1.05M	Sell	63,520 -1,480	-2%	-$25.9K	﹤0.01%	685
2015 Q4	$1.41M	Buy	+65,000	New	+$1.27M	﹤0.01%	684

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

ClearBridge Investments's HZNP Position: Q4 2023 in Review

ClearBridge Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 105,901 shares — an estimated $12.3M sold.

ClearBridge Investments first reported a position in HZNP in Q4 2015 and held it in 17 quarters. The position peaked at $189M in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

ClearBridge Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
ClearBridge Investments sold 105,901 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $12.3M.
ClearBridge Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015 and held it in 17 quarters.
ClearBridge Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $189M in Q1 2022.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on ClearBridge Investments's 13F filing for Q4 2023, filed 9 Feb 2024.